Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-24.64	101.32	134.44
Graham Fair Price	9.32	2.89	2.65
PEG	-21.89	2.04	-2.61
Price/Book	-13.33	3.54	4.08
Price/Cash Flow	-67.62	32.61	-100.69
Prices/Earnings	-24.98	35.62	47.48
Price/Sales	-18.78	7.21	8.87
Price/FCF	-67.62	32.61	-100.69
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-8.97	0.07	0.08
Operating Margin	1.26	0.05	0.05
ROA	16.44	0.02	0.01
ROE	0.02	0.02	15.52
ROIC	0.02	0.02	-7.64
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.13	0.35	-61.95
Dividends QOQ	-0.94	17.14	1715.23
EBIT QOQ	3.63	0.10	-97.27
EPS QOQ	-0.18	0.17	-3.95
FCF QOQ	-12.36	3.72	-69.89
Revenue QOQ	0.24	0.09	-63.93
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	12.54	10.92	-12.90
Days Sales Outstanding (DSO)	32.56	27.56	-15.37
Inventory Turnover	7.18	8.24	14.81
Debt/Capitalization	0.15	0.13	-12.67
Quick Ratio	1.32	1.53	16.11
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	3.80	4.17	9.64
Cash	1.15	1.41	22.76
Capex	-0.15	0.12	-22.10
Free Cash Flow	-0.15	0.42	172.23
Revenue	1.75	1.90	8.53
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.54	1.69	10.01
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.75	0.53	-30.08
Naive Interpretation	Member

06 - Financial Health · Weak

Rating